The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D.
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
PMID:33782057
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.
Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE.
BMJ. 2021 Mar 29;372:n160. doi: 10.1136/bmj.n160.
PMID:33781993
Consort 2010 statement: extension to cluster randomised trials.
Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable.
Whitehead AL, Julious SA, Cooper CL, Campbell MJ.
Stat Methods Med Res. 2016 Jun;25(3):1057-73. doi: 10.1177/0962280215588241. Epub 2015 Jun 19.
PMID:26092476
Framework for design and evaluation of complex interventions to improve health.
Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P.